HCA Healthcare (NYSE:HCA) Given New $392.00 Price Target at Barclays

HCA Healthcare (NYSE:HCA) had its target price trimmed by Barclays from $396.00 to $392.00 in a research note published on Friday,Benzinga reports. The firm currently has an overweight rating on the stock.

A number of other analysts have also recently weighed in on HCA. UBS Group increased their price target on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Cantor Fitzgerald reissued an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Truist Financial lifted their price objective on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Finally, Wells Fargo & Company raised their target price on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research report on Wednesday. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $379.17.

HCA Healthcare Stock Performance

HCA Healthcare stock traded down $1.87 during mid-day trading on Friday, reaching $354.16. The company’s stock had a trading volume of 1,252,655 shares, compared to its average volume of 1,542,979. The business has a 50 day moving average price of $389.61 and a 200-day moving average price of $356.03. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. HCA Healthcare has a twelve month low of $226.48 and a twelve month high of $417.14. The firm has a market cap of $89.71 billion, a price-to-earnings ratio of 15.90, a PEG ratio of 1.34 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a $0.66 dividend. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.75%. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Capital World Investors increased its stake in shares of HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after acquiring an additional 1,019,750 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $131,527,000. Darsana Capital Partners LP increased its holdings in HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock worth $369,472,000 after buying an additional 400,000 shares during the last quarter. Swedbank AB acquired a new stake in HCA Healthcare in the first quarter valued at approximately $95,882,000. Finally, TD Asset Management Inc raised its holdings in shares of HCA Healthcare by 30.4% during the 1st quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock valued at $240,581,000 after purchasing an additional 168,093 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.